Welcome to our dedicated page for Ryerson Holding SEC filings (Ticker: RYI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Ryerson Holding's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Ryerson Holding's regulatory disclosures and financial reporting.
The filing is a Form 144 notice reporting a proposed sale of 2,250 common shares through Fidelity Brokerage Services LLC on 10/03/2025. The shares have an aggregate market value of $54,247.50 and the issuer shows 32,198,906 shares outstanding. The securities are listed on the NYSE. The acquisition row states the securities were acquired via an option granted on 03/31/2021 and are recorded with an acquisition date of 10/03/2025, with payment in cash. No other sales in the past three months are reported and the filing contains the standard signature/representation language required by Rule 144.
Karen Marie Leggio, a director of Ryerson Holding Corp (RYI), received 382 shares of common stock as director compensation on 09/30/2025. The award vested in full on the grant date and was issued at no cash cost ($0 reported). After the grant, Ms. Leggio beneficially owned 4,536 shares. The Form 4 was filed by an attorney-in-fact and signed on 10/02/2025. The filing discloses no derivative transactions and states the award was made under Ryerson's Director Compensation Program.
Stephen P. Larson, a director of Ryerson Holding Corp (RYI), received 929 shares of common stock as compensation under the company's Director Compensation Program on 09/30/2025. The award vested in full on the grant date and was recorded at a $0 per-share transaction price for reporting purposes. After this transaction, Mr. Larson is reported to beneficially own 95,687 shares. The Form 4 was signed by an attorney-in-fact on 10/02/2025. The filing discloses a routine, vested equity award to a director and provides no additional financial metrics or derivative activity.
Ryerson Holding Corp director Michelle Kumbier received an equity award under the company's Director Compensation Program that was granted and vested in full on 09/30/2025. The Form 4 reports acquisition of 382 shares of Ryerson common stock at a reported price of $0, reflecting compensation rather than a market purchase. Following the transaction, the reporting person beneficially owns 2,409 shares in total. The filing is signed by an attorney-in-fact on 10/02/2025 and includes an explanation that the grant vested on the grant date.
Ryerson Holding Corp (RYI) director Court D. Carruthers reported an equity award received under the companys Director Compensation Program. On 09/30/2025 the reporting person was issued 382 shares of common stock that vested in full on the grant date and carried an acquisition price of $0 as disclosed.
After the transaction the reporting person beneficially owned 5,340 shares. The Form 4 was signed by an attorney-in-fact on 10/02/2025. The filing states the issuance reflects director compensation and contains no additional financial terms or derivative transactions.
Ryerson Holding Corp director Kirk K. Calhoun received an equity award under the companys Director Compensation Program that vested in full on the grant date. The reported transaction dated 09/30/2025 shows an acquisition of 382 shares of common stock at a reported price of $0 as compensation. Following the award, the reporting person beneficially owns 3,840 shares, held directly. The filing is a Form 4 reporting a routine, vested director equity grant disclosed under Section 16 reporting rules and was signed by an attorney-in-fact on 10/02/2025. The filer checked the box indicating they are a Director.
Ryerson Holding Corp (RYI) Form 4 discloses that Sundarrajan Alagu, Chief Information Officer and reporting person, received additional restricted stock units (RSUs) and accrued dividend equivalent rights on 09/18/2025. The filing shows three grants of RSUs that reflect dividend equivalents of 16.613, 32.496, and 53.758 units, which correspond to underlying common stock amounts of 2,074.819, 4,058.497, and 6,713.948 shares respectively, all with $0 price. The filing explains vesting schedules: awards from 2023 vest on 03/31/2026, 2024 awards vest on 03/31/2026 and 03/31/2027, and 2025 awards vest on 03/31/2026, 03/31/2027 and 03/31/2028. The Form 4 was signed by attorney-in-fact on 09/22/2025.
Silver Mark S., EVP, GC & Chief HR Officer of Ryerson Holding Corporation (RYI) reported transactions on 09/18/2025 related to restricted stock units. The Form 4 shows acquisition entries of dividend-equivalent rights tied to existing restricted stock units, recorded at a $0 price. The entries list amounts of 23.732, 46.419 and 80.637 and show resulting beneficial ownership figures of 2,963.883, 5,797.414 and 10,070.922 common shares respectively. Explanations state each RSU converts to one share, dividend equivalents accrue with company dividends, and the awards vest on staggered dates through March 31, 2028.
Molly D. Kannan, Chief Accounting Officer and Corporate Controller of Ryerson Holding Corp (RYI), reported acquisitions of dividend equivalent rights tied to restricted stock units (RSUs). Each RSU represents a contingent right to one share of RYI common stock. On 09/18/2025 she acquired dividend equivalent amounts of 16.613, 32.496 and 53.758 share equivalents, which increased her beneficial ownership in the underlying common stock to 2,074.819, 4,058.497 and 6,713.948 respectively. The accrued dividend equivalents relate to RSU grants from March 31, 2023, 2024 and 2025 and will vest on specified dates between March 31, 2026 and March 31, 2028 under the awards' original vesting schedules.
James J. Claussen, Executive Vice President & Chief Financial Officer of Ryerson Holding Corp (RYI), reported the grant and accrual of restricted stock units (RSUs) and related dividend equivalent rights on 09/18/2025. Each RSU represents a contingent right to one share of common stock and the reported dividend equivalents were granted at $0 price. The filing shows cumulative beneficial ownership following the transactions of 4,149.637, 8,115.974 and 13,427.895 shares tied to RSU awards granted March 31, 2023, 2024 and 2025. The awards remain unvested with scheduled vesting dates through March 31, 2028. The form was signed by attorney-in-fact on 09/22/2025.